In a report released today, Difei Yang from Mizuho Securities maintained a Hold rating on Nektar Therapeutics (NKTR – Research
Category: Healthcare
Collegium Pharmaceutical (COLL) Received its Third Buy in a Row
After Jefferies and Piper Jaffray gave Collegium Pharmaceutical (NASDAQ: COLL) a Buy rating last month, the company received another Buy,
Rocket Pharmaceuticals (RCKT) Received its Third Buy in a Row
After Cowen & Co. and William Blair gave Rocket Pharmaceuticals (NASDAQ: RCKT) a Buy rating last month, the company received
Analysts Offer Insights on Healthcare Companies: SAGE Therapeutics (NASDAQ: SAGE) and Rocket Pharmaceuticals (NASDAQ: RCKT)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on SAGE Therapeutics
Ladenburg Thalmann & Co. Downgrades SAGE Therapeutics (SAGE) to Hold
In a report released today, Michael Higgins from Ladenburg Thalmann & Co. downgraded SAGE Therapeutics (SAGE – Research Report) to
Maxim Group Initiates a Buy Rating on Soliton (SOLY)
Soliton (SOLY – Research Report) received a Buy rating and a $22.00 price target from Maxim Group analyst Anthony Vendetti
Analysts Offer Insights on Healthcare Companies: SAGE Therapeutics (NASDAQ: SAGE) and Puma Biotechnology (NASDAQ: PBYI)
Analysts have been eager to weigh in on the Healthcare sector with new ratings on SAGE Therapeutics (SAGE – Research